in a prospective , randomized trial , norfloxacin ( 400 mg perorally , twice a day ) was compared with trimethoprim-sulfamethoxazole ( 160-800 mg perorally , twice a day ) in 45 patients with uncomplicated urinary tract infections .
C0028365
norfloxacin
C0042029
urinary tract infections